| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |